Neurologic Features in Severe SARS-CoV-2 Infection
NEJM 382:2268-2270, e110, , 2020
Diagnosis and Treatment of Acute Encephalitis
The Neurologist 6:145-159, Davis,L.E., 2000
Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
NEJM 380:1597-1605, Cortese, I.,et al, 2019
Progressive Multifocal Leukoencephalopathy: Epidemiology, Clinical Manifestations, and Diagnosis
www.UptoDate.com, May, Koralnik, I.J., 2018
Viral Infections of the Nervous System, Chronic Meningitis, and Prior Diseases, Progressive Multifocal Leukoencephalopathy
Adams & Victors Principles of Neurology, Chp 33, pg 767, Ropper, A.H.,et al, 2014
Progressive Multifocal Leukoencephalopathy: Prognosis and treatment
UpToDate, June, Koralnik, I.J.,et al, 2011
Oral Acyclovir Suppression and Neurodevelopment after Neonatal Herpes
NEJM 365:1284-1292,1338, Kimberlin, D.W.,et al, 2011
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
NEJM 362:402-415, 456, Cohen,J.A.,et al, 2010
JC Virus Infection of the Brain
AJNR 31:1564-1576, Bag,A.K.,et al, 2010
Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009
Tick-Borne Encephalitis
Lancet 371:1861-1871, Lindquist,L. &Vapalahti,O., 2008
Rapidly Progressive Dementia
Ann Neurol 64:97-108, Geschwind,M.D.,et al., 2008
Reactivation of JC Virus and Development of PML in Patients With Multiple Sclerosis
Neurol 68:985-990, Khalili,K.,et al, 2007
Characteristics and Antecedents of Progressive Multifocal Leukoencephalopathy in an Insured Population
Neurol 67:884-886, Eng,P.M.,et al, 2006
FDA Public Health advisory-Suspended Marketing of Tysabri (natalizumab)
www.fda.gov/cder/drug/advisory/natalizumab.htm.,(Feb 28), US Food and Drug Admin., 2005
La Crosse Encephalitis in Children
NEJM 344:801-807, McJunkin,J.E.,et al, 2001
Acute Viral Encephalitis in Childhood
BMJ 310:139-140, Kennedy,C., 1995
Cerebrospinal Fluid
JNNP 59:349-357, Thompson,E.J., 1995
Transverse Myelitis, Retrosp Analy of 33 Cases, with Diff Cases Assoc with MS & Parinfectious Events
Arch Neurol 50:532-535, Jeffery,D.R.,et al, 1993
Efficacy of Cytarabine in Progressive Multifocal Leucoencephalopathy in AIDS
Lancet 339:306, Nicoli,F.,et al, 1992
Progressive Multifocal Leukoencephalopathy-Remission with Cytarabine
J Infection 20:51-54, O'Riordan,T.,et al, 1990
Neurologic Manifestations of AIDS
Medicine 66:407-437, McArthur,J.C., 1987
Progressive Multifocal Leukoencephalopathy Associated with Human Immunodeficiency Virus Infection
Ann Int Med 107:78-87, Berger,J.R., 1987
Neurological Complications of Acquired Immune Deficiency Syndrome:Analysis of 50 Patients
Ann Neurol 14:403-418, Snider,W.D.,et al, 1983
Fewer COVID-19 Neurological Complications with Dexamethasone and Remdesivir
Ann Neurol 93:88-102, Grundmann,A.,et al, 2023
Impacts of Climate Change and Air Pollution on Neurologic Health, Disease, and Practice, A Scoping Review
Neurol 100:474-483, Louis,S.,et al, 2023
Monkeypox-Associated Central Nervous System Disease:A Case Series and Review
Ann Neurol 93:893-905, Money,K.M.,et al, 2023
Neurologic Manifestations of Long COVID Differ Based on Acute COVID-19 Severity
Ann Neurol 94:146-159, Giraldo,G.S.P.,et al, 2023
Unpacking the CNS Manifestations of Epstein-Barr Virus:An Imaging Perspective
AJNR 44:1002-1008, Soni,N.,et al, 2023
Progressive Multifocal Leukoencephalopathy in a Patient with Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy
JAMA Neurol 78:736-740, Patel,A.,et al, 2021
COVID-19: A Global Threat to the Nervous System
Ann Neurol 88:1-11, Koralnik, I.J. & Tyler, K.L., 2020
The COVID-19 Pandemic and the Ethical Duties of the Neurologist
Neurol 95:167-172, Rubin, M.A.,et al, 2020
Clinical and Radiologic Findings of Acute Necrotizing Encephalopathy in Young Adults
AJNR 41:2250-2254, Vanjare, H.A.,et al, 2020
A Case of Monocytic Pleocytosis in West Nile Virus Encephalitis and Review of the Literature
Case Reports 23:687-688, Villafuerte, B.J.,et al, 2020
Acute Encephalitis in Immunocompetent Adults
Lancet 393:702-716, Venkatesan, A.,et al, 2019
Clinicopathologic Conference, Human Herpesvirus 6-Related Meningoencephalitis
NEJM 378:659-669, Case 5-2018, 2018
Acute Viral Encephalitis
NEJM 379:357-366, Tyler,K.L., 2018
A Man with Rapidly Progressive Weakness and Respiratory Failure
Neurol 91:e686-e691, Xu,D.,et al, 2018
Neuroimaging Findings of Zika Virus-Associated Neurologic Complications in Adults
AJNR 39:1967-1974, Hygino da Cruz, L.C.,et al, 2018
Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab
Emerg Inf Dis 24:1594-1596, Martinot, M.,et al, 2018
Cytotoxic Lesions of the Corpus Callosum That Show Restricted Diffusion: Mechanisms, Causes, and Manifestations
RadioGraphics 37:562-576, Starkey, J.,et al, 2017
Zika Virus as a Cause of Neurologic Disorders
NEJM 374:1506-1509, Broutet, N.,et al, 2016
Zika Virus
NEJM 374:1552-1563, Petersen, L.R.,et al, 2016
Zika Virus as an Emerging Global Pathogen
JAMA Neurol 73:875-879, Beckham, J.D.,et al, 2016
Acute Flaccid Myelitis; A Clinical Review of US Cases 2012-2015
Ann Neurol 80:326-338, Messacar, K.,et al, 2016
Zika Virus: An Emergent Neuropathological Agent
Ann Neurol 80:479-489, White, M.K.,et al, 2016
Armies of Pestilence: CNS Infections as Potential Weapons of Mass Destruction
AJNR 36:1018-1024, Hart, B.L. & Ketai, L., 2015
Rotavirus-Associated Mild Encephalopathy with a Reversible Splenial Lesion (MERS)
BMC Infect Dis 15:446, Karampatsas, K.,et al, 2015
Viral Infections of the Nervous System, Chronic Meningitis, and Prior Diseases, Acute Encephalitis
Adams & Victors Principles of Neurology, Chp 33, pg 748, Ropper, A.H.,et al, 2014